Risks Associated With the Non-Medicinal Use of Cannabis
Open accessThe DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Cannabis is the most commonly consumed illicit drug around the world; in Germany, about 4.5% of all adults use it each year. Intense cannabis use is associated with health risks. Evidence-based treatments are available for health problems caused by cannabis use. METHODS: Selective literature review based on a search of the PubMed database, with special emphasis on systematic reviews, meta-analyses, cohort studies, randomized controlled trials (RCTs), case-control studies, and treatment guidelines. RESULTS: The delta-9-tetrahydrocannabinol content of cannabis products is rising around the world as a result of plant breeding, while cannabidiol, in contrast, is often no longer detectable. Various medical conditions can arise acutely after cannabis use, depending on the user's age, dose, frequency, mode and situation of use, and individual disposition; these include panic attacks, psychotic symptoms, deficient attention, impaired concentration, motor incoordination, and nausea. In particular, intense use of high doses of cannabis over many years, and the initiation of cannabis use in adolescence, can be associated with substance dependence (DSM-5; ICD-10), specific withdrawal symptoms, cognitive impairment, affective disorders, psychosis, anxiety disorders, and physical disease outside the brain (mainly respiratory and cardiovascular conditions). At present, the most effective way to treat cannabis dependence involves a combination of motivational encouragement, cognitive behavioral therapy, and contingency management (level 1a evidence). For adolescents, family therapy is also recommended (level 1a evidence). No pharmacological treatments can be recommended to date, as evidence for their efficacy is lacking. CONCLUSION: Further research is needed to elucidate the causal relationships between intense cannabis use and potential damage to physical and mental health. Health problems due to cannabis use can be effectively treated.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cannabinoid receptor localization in brain.
Herkenham, M., Lynn, A. B., Little, M. D., Johnson, M. R., Melvin, L. S., de Costa, B. R., & Rice, K. C. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.5.1932 · Cited by 2,321
Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review.
Moore, T. H., Zammit, S., Lingford-Hughes, A., Barnes, T. R., Jones, P. B., Burke, M., & Lewis, G. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61162-3 · Cited by 2,224
Persistent cannabis users show neuropsychological decline from childhood to midlife
Meier, M. H., Caspi, A., Ambler, A., Harrington, H., Houts, R., Keefe, R. S. E., McDonald, K., Ward, A., Poulton, R., & Moffitt, T. E. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1206820109 · Cited by 1,523 · cited 2×
“One of the highest-quality studies is by Meier and colleagues (4).”
BackgroundResultA Meta-Analytic Review of Psychosocial Interventions for Substance Use Disorders
Dutra, L., Stathopoulou, G., Basden, S. L., Leyro, T. M., Powers, M. B., & Otto, M. W. (2008) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2007.06111851 · Cited by 1,287
Lev-Ran, S., Roerecke, M., Le Foll, B., George, T. P., McKenzie, K., & Rehm, J. (2014) · Psychological Medicine · doi:10.1017/s0033291713001438 · Cited by 589
Cannabis use disorders in the USA: prevalence, correlates and co-morbidity
STINSON, F. S., RUAN, W. J., PICKERING, R., & GRANT, B. F. (2006) · Psychological Medicine · doi:10.1017/s0033291706008361 · Cited by 422
Cannabis as a risk factor for psychosis: Systematic review
Semple, D. M., McIntosh, A. M., & Lawrie, S. M. (2005) · Journal of Psychopharmacology · doi:10.1177/0269881105049040 · Cited by 420
Bossong, M. G., & Niesink, R. J. M. (2010) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2010.06.010 · Cited by 333
Cannabis use and educational achievement: Findings from three Australasian cohort studies
Horwood, L. J., Fergusson, D. M., Hayatbakhsh, M. R., Najman, J. M., Coffey, C., Patton, G. C., Silins, E., & Hutchinson, D. M. (2010) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2010.03.008 · Cited by 302
Budney, A. J., Moore, B. A., Rocha, H. L., & Higgins, S. T. (2006) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.4.2.307 · Cited by 290
Lisdahl, K. M., Gilbart, E. R., Wright, N. E., & Shollenbarger, S. (2013) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2013.00053 · Cited by 284
Self-reported cannabis use characteristics, patterns and helpfulness among medical cannabis users
Bonn-Miller, M. O., Boden, M. T., Bucossi, M. M., & Babson, K. A. (2014) · The American Journal of Drug and Alcohol Abuse · doi:10.3109/00952990.2013.821477 · Cited by 281
Degenhardt, L., Dierker, L., Chiu, W. T., Medina-Mora, M. E., Neumark, Y., Sampson, N., Alonso, J., Angermeyer, M., Anthony, J. C., Bruffaerts, R., et al. (2010) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2009.12.001 · Cited by 271
Tests of causal linkages between cannabis use and psychotic symptoms
Fergusson, D. M., Horwood, L. J., & Ridder, E. M. (2005) · Addiction · doi:10.1111/j.1360-0443.2005.01001.x · Cited by 268
Nabiximols as an Agonist Replacement Therapy During Cannabis Withdrawal: A Randomized Clinical Trial
Allsop, D. J., Copeland, J., Lintzeris, N., Dunlop, A. J., Montebello, M., Sadler, C., Rivas, G. R., Holland, R. M., Muhleisen, P., Norberg, M. M., et al. (2014) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2013.3947 · Cited by 266
Degenhardt, L., Coffey, C., Romaniuk, H., Swift, W., Carlin, J. B., Hall, W. D., & Patton, G. C. (2013) · Addiction · doi:10.1111/j.1360-0443.2012.04015.x · Cited by 237
Levin, F. R., Mariani, J. J., Brooks, D. J., Pavlicova, M., Cheng, W., & Nunes, E. V. (2011) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2010.12.010 · Cited by 232
Abstinence rates following behavioral treatments for marijuana dependence
Kadden, R. M., Litt, M. D., Kabela-Cormier, E., & Petry, N. M. (2007) · Addictive Behaviors · doi:10.1016/j.addbeh.2006.08.009 · Cited by 173
Strakowski, S. M., DelBello, M. P., Fleck, D. E., Adler, C. M., Anthenelli, R. M., Keck, P. E., Arnold, L. M., & Amicone, J. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.1.57 · Cited by 165
Davis, M. L., Powers, M. B., Handelsman, P., Medina, J. L., Zvolensky, M., & Smits, J. A. J. (2015) · Evaluation & the Health Professions · doi:10.1177/0163278714529970 · Cited by 114
Feng, B.-J., Khyatti, M., Ben-Ayoub, W., Dahmoul, S., Ayad, M., Maachi, F., Bedadra, W., Abdoun, M., Mesli, S., Bakkali, H., et al. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6605281 · Cited by 109
Hoch, E., Bühringer, G., Pixa, A., Dittmer, K., Henker, J., Seifert, A., & Wittchen, H. U. (2014) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2013.09.028 · Cited by 79
Self-citationCrippa, J. A., Derenusson, G. N., Chagas, M. H., Atakan, Z., Martín-Santos, R., Zuardi, A. W., & Hallak, J. E. (2012) · Harm Reduction Journal · doi:10.1186/1477-7517-9-7 · Cited by 45
Tetrault, J. M. (2007) · Archives of Internal Medicine · doi:10.1001/archinte.167.3.221 · Cited by 4
Cited by
The cannabis withdrawal syndrome: current insights
Bonnet, U., & Preuss, U. (2017) · Substance Abuse and Rehabilitation · doi:10.2147/sar.s109576 · Cited by 221
“This was related with a mounting number of patients seeking treatment due to various cannabis-related disorders, including cognitive deficits, psychosis, and dependence.(4,5) Considering these populations and also nontreatment-seeking cannabis-dependent individuals, larger retrospective clinical trials(10,11) demonstr…”
Self-citationHow effective and safe is medical cannabis as a treatment of mental disorders? A systematic review
Hoch, E., Niemann, D., von Keller, R., Schneider, M., Friemel, C. M., Preuss, U. W., Hasan, A., & Pogarell, O. (2019) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-019-00984-4 · Cited by 131
Self-citationTafelski, S., Häuser, W., & Schäfer, M. (2016) · Der Schmerz · doi:10.1007/s00482-015-0092-3 · Cited by 71
Xue, S., Husain, M. I., Zhao, H., & Ravindran, A. V. (2021) · The Canadian Journal of Psychiatry · doi:10.1177/0706743720952251 · Cited by 65
A Review of Cases of Marijuana and Violence
Miller, N. S., Ipeku, R., & Oberbarnscheidt, T. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17051578 · Cited by 36
“When people stop using marijuana they may experience a variety of withdrawal symptoms, including sleep disturbance, irritability or restlessness, loss of appetite, anxiety, and sweating [46,58].”
Background
Metadata
- Authors
- Hoch, E., Bonnet, U., Thomasius, R., Ganzer, F., Havemann-Reinecke, U., & Preuss, U. W.
- Venue
- Deutsches Ärzteblatt international
- Publisher
- Deutscher Arzte-Verlag GmbH
- Published
- 2015-04-17
- Volume
- 112
- Issue
- 16
- Pages
- 271-8
- ISSN
- 1866-0452 (ISSN-L)
- OpenAlex
- W1517132771
- Cited by
- 128
- References
- 24
- FWCI
- 10.79
- Type
- journal article
- Language
- de
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.